Prab: CSV import

2025-02-15T11:00:11Z

CSV import

← Older revision		Revision as of 11:00, 15 February 2025
Line 1:		Line 1:
	~~'''~~Ibrolipim''' is a [[lipid-lowering agent]] that is used in the treatment of [[hyperlipidemia]] and [[diabetes]]. It is a [[fatty acid]] derivative that has been shown to increase [[HDL cholesterol]] levels and decrease [[LDL cholesterol]] levels in the body.		== Ibrolipim ==

	~~== Mechanism~~ of ~~Action ==~~		[[File:Ibrolipim_structure.svg\|thumb\|right\|Chemical structure of Ibrolipim]]

	Ibrolipim ~~works by inhibiting~~ the ~~enzyme~~ [[~~lipoprotein lipase~~]], ~~which is responsible for~~ the ~~breakdown~~ of [[~~triglycerides~~]] ~~in the body. By inhibiting this enzyme~~, ~~Ibrolipim reduces the amount of triglycerides that~~ are ~~broken down, leading to a decrease in the overall level of triglycerides in the body. This can help~~ to reduce the risk of [[cardiovascular disease]].		'''Ibrolipim''' is a pharmaceutical compound used primarily in the treatment of [[hyperlipidemia]], a condition characterized by elevated levels of lipids in the blood. It belongs to a class of drugs known as [[lipid-lowering agents]], which are used to manage and reduce the risk of [[cardiovascular disease]].

	== ~~Uses~~ ==		== Mechanism of Action ==
			Ibrolipim functions by inhibiting the synthesis of [[cholesterol]] in the liver. It acts on the [[enzyme]] [[HMG-CoA reductase]], which plays a crucial role in the [[mevalonate pathway]], a metabolic pathway that produces cholesterol and other isoprenoids. By inhibiting this enzyme, Ibrolipim effectively reduces the production of cholesterol, leading to decreased levels of [[low-density lipoprotein]] (LDL) cholesterol in the bloodstream.

	Ibrolipim is ~~primarily used in the treatment of hyperlipidemia~~ and ~~diabetes~~. It ~~can be~~ used ~~alone or~~ in ~~combination~~ with ~~other~~ lipid~~-lowering agents~~. ~~In addition to its lipid-lowering effects, Ibrolipim has also been shown to have anti-inflammatory~~ and ~~anti~~-~~oxidative effects, which can be beneficial in the treatment of these conditions~~.		== Clinical Use ==
			Ibrolipim is prescribed to patients with [[dyslipidemia]], particularly those with high LDL cholesterol levels that are not adequately controlled by [[diet]] and [[exercise]]. It is often used in conjunction with lifestyle modifications to achieve optimal lipid levels. The drug is administered orally and is typically well-tolerated by patients.

	== Side Effects ==		== Side Effects ==
			Common side effects of Ibrolipim include [[gastrointestinal]] disturbances such as [[nausea]], [[diarrhea]], and [[abdominal pain]]. Some patients may experience [[muscle pain]] or [[weakness]], which should be reported to a healthcare provider as it may indicate a more serious condition known as [[rhabdomyolysis]].
	~~Like all medications, Ibrolipim can cause side effects. The most common~~ side effects of Ibrolipim include [[~~nausea~~]], [[~~vomiting~~]], [[diarrhea]], and [[abdominal pain]]. ~~Less common side effects can include~~ [[~~rash]], [[itching~~]]~~, and~~ [[~~hives~~]]~~. If you experience any of these side effects while taking Ibrolipim~~, ~~you~~ should ~~contact your~~ [[~~healthcare provider~~]] ~~immediately~~.

	== Contraindications ==		== Contraindications ==
			Ibrolipim is contraindicated in patients with [[liver disease]] or unexplained persistent elevations of [[serum transaminases]]. It should be used with caution in patients with a history of [[alcohol abuse]] or those taking other medications that may affect liver function.

	Ibrolipim should not be used in individuals with a known [[allergy]] to the medication. It should also not be used in individuals with severe [[liver disease]] or [[kidney disease]], as these conditions can affect the way the body metabolizes and eliminates the medication.		== Related Pages ==

	== ~~See Also~~ ==

	* [[Lipid-lowering agent]]
	* [[Hyperlipidemia]]		* [[Hyperlipidemia]]
	* [[~~Diabetes]]~~		* [[Cholesterol]]
			* [[HMG-CoA reductase]]
	~~== References ==~~		* [[Cardiovascular disease]]

	~~<references />~~

	~~[[Category:Pharmacology]]~~
	~~[[Category:Medications~~]]
	[[~~Category:Diabetes~~]]
	[[~~Category:Hyperlipidemia~~]]

	~~{{pharmacology~~-~~stub}}~~		[[Category:Pharmaceutical drugs]]
			[[Category:Lipid-lowering agents]]

Prab: CSV import

2024-03-08T18:52:24Z

CSV import

New page

'''Ibrolipim''' is a [[lipid-lowering agent]] that is used in the treatment of [[hyperlipidemia]] and [[diabetes]]. It is a [[fatty acid]] derivative that has been shown to increase [[HDL cholesterol]] levels and decrease [[LDL cholesterol]] levels in the body.

== Mechanism of Action ==

Ibrolipim works by inhibiting the enzyme [[lipoprotein lipase]], which is responsible for the breakdown of [[triglycerides]] in the body. By inhibiting this enzyme, Ibrolipim reduces the amount of triglycerides that are broken down, leading to a decrease in the overall level of triglycerides in the body. This can help to reduce the risk of [[cardiovascular disease]].

== Uses ==

Ibrolipim is primarily used in the treatment of hyperlipidemia and diabetes. It can be used alone or in combination with other lipid-lowering agents. In addition to its lipid-lowering effects, Ibrolipim has also been shown to have anti-inflammatory and anti-oxidative effects, which can be beneficial in the treatment of these conditions.

== Side Effects ==

Like all medications, Ibrolipim can cause side effects. The most common side effects of Ibrolipim include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. Less common side effects can include [[rash]], [[itching]], and [[hives]]. If you experience any of these side effects while taking Ibrolipim, you should contact your [[healthcare provider]] immediately.

== Contraindications ==

Ibrolipim should not be used in individuals with a known [[allergy]] to the medication. It should also not be used in individuals with severe [[liver disease]] or [[kidney disease]], as these conditions can affect the way the body metabolizes and eliminates the medication.

== See Also ==

* [[Lipid-lowering agent]]
* [[Hyperlipidemia]]
* [[Diabetes]]

== References ==

<references />

[[Category:Pharmacology]]
[[Category:Medications]]
[[Category:Diabetes]]
[[Category:Hyperlipidemia]]

{{pharmacology-stub}}

Ibrolipim - Revision history

Prab: CSV import

Prab: CSV import